For patients with ongoing SLE clinical/serologic activity despite ongoing treatment for lymphoma with agents targeting B cell proliferation, it's probably safe to use belimumab if needed in this setting. Thus far, reported experiences and our own using belimumab in patients who have undergone B cell...